Subscribe To
SPPI / Spectrum Pharmaceuticals, Inc. (SPPI) Q4 2022 Earnings Call Transcript
Content Topics
Spectrum
Pharmaceuticals
Inc
SPPI
2022
Earnings
Call
Pharmaceuticals
sppi
Transcript
Stock
SPPI News
By Seeking Alpha
June 22, 2023
Spectrum's Rolvedon A Differentiator In A $3B/Yr Market
Spectrum and Assertio's merger would lead to a diversified product portfolio and a combination of two unique marketing strategies. Spectrum's ROLVEDON more_horizontal
By Zacks Investment Research
May 9, 2023
Spectrum Pharmaceuticals (SPPI) Reports Q1 Loss, Tops Revenue Estimates
Spectrum Pharmaceuticals (SPPI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compare more_horizontal
By InvestorPlace
April 25, 2023
Why Is Spectrum Pharmaceuticals (SPPI) Stock Up 35% Today?
Spectrum Pharmaceuticals (NASDAQ: SPPI ) stock is soaring higher on Tuesday thanks to an acquisition deal with Assertio (NASDAQ: ASRT ). This deal w more_horizontal
By Seeking Alpha
March 22, 2023
Spectrum Pharmaceuticals, Inc. (SPPI) Q4 2022 Earnings Call Transcript
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI ) Q4 2022 Earnings Conference Call March 22, 2023 8:30 AM ET Company Participants Thomas Riga - President more_horizontal
By Business Wire
March 17, 2023
Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update
BOSTON--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies more_horizontal
By Zacks Investment Research
November 28, 2022
Spectrum's (SPPI) NDA for NSCLC Candidate Gets CRL From FDA
Spectrum (SPPI) gets a CRL from the FDA for poziotinib as the agency requires additional data. The company de-prioritized the poziotinib program. more_horizontal
By PennyStocks
September 9, 2022
Penny Stocks To Buy: The Good, Bad, & Ugly & 3 To Watch Now
Whether you're a seasoned trader making money with penny stocks or just more_horizontal
By Seeking Alpha
August 11, 2022
Spectrum Pharmaceuticals, Inc. (SPPI) CEO Thomas Riga on Q2 2022 Results - Earnings Call Transcript
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI ) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Michael Grabow - SVP, C more_horizontal